Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience.

Daniel S PetkovsekDaniel G CherfanFelipe F ContiGrant L HomJustin P EhlersAmy S BabiuchAleksandra V RachitskayaPeter K KaiserAndrew P SchachatSunil K SrivastavaSumit SharmaRishi P Singh

Published in: The British journal of ophthalmology (2019)

Anatomical improvement occurs primarily within the first year of eplerenone treatment for chronic CSCR.

Keyphrases

high grade
combination therapy
drug induced